コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 troke severity (National Institute of Health Stroke Scale).
2 n score on the National Institutes of Health Stroke Scale.
3 h as discharge National Institutes of Health Stroke Scale.
5 severity (per National Institutes of Health Stroke Scale 10-point increase, OR 1.54; 95% CI 1.05 to
6 verity (median National Institutes of Health Stroke Scale, 11 [6-19] versus 11 [6-18]; absolute stand
8 edian baseline National Institutes of Health Stroke Scale = 14 (interquartile range [IQR] = 11-20), a
9 omen, baseline National Institutes of Health Stroke Scale 18, and the time to study drug was 9.1 +/-
10 (73+/-9 years, National Institute of Health Stroke Scale 2+/-2, mobile 10 metres with/without aid) w
11 DOACs (median National Institutes of Health Stroke Scale 4, [interquartile range 2-11]) compared wit
12 women, median National Institutes of Health Stroke Scale 5 [IQR 3-10]) in the individual patient dat
14 d positive if the sum of the age and the NIH Stroke Scale (a 15-item neurological examination scale w
15 CI, 4.83-5.53; National Institutes of Health Stroke Scale adjusted odds ratio, 3.57; 95% CI, 3.15-4.0
16 iated with the National Institutes of Health Stroke Scale+age score and 30-day mortality after ischem
17 ion and fatigue after correcting for the NIH Stroke Scale, age, benzodiazepine exposure, and time of
18 tly better than National Institute of Health Stroke Scale alone regarding prediction error (Wilcoxon
20 duction in the National Institutes of Health Stroke Scale and a favorable odds ratio of a modified Ra
21 ents had higher National Institute of Health Stroke Scale and ABCD2 scores and presented more frequen
22 = 0.018) after correction for admission NIH Stroke Scale and age, and with worse QOL in the domains
23 n for baseline National Institutes of Health Stroke Scale and age, to treatment with desmoteplase (90
24 with documented National Institute of Health Stroke Scale and in a cohort of patients with stroke ext
27 stment, higher National Institutes of Health Stroke Scale and proxy assessments were independently as
29 as measured by National Institutes of Health Stroke Scale) and computer tomography changes (as measur
30 or more on the National Institutes of Health Stroke Scale, and a CT or MRI ruling out intracranial ha
33 0.007), higher National Institutes of Health Stroke Scale, and intracerebral hemorrhage scores (P<0.0
34 l thrombectomy, National Institute of Health Stroke Scale, antiplatelets, anticoagulation, temperatur
35 inical outcome (National Institute of Health Stroke Scale at 72 hours) was negatively associated with
36 y to the score: National Institute of Health Stroke Scale at admission, hemineglect, female sex, atri
38 ssed using the National Institutes of Health Stroke Scale, Barthel Index and modified Rankin Scale.
39 or more on the National Institutes of Health Stroke Scale between baseline and day 30 or a score of 0
40 gia screening, National Institutes of Health Stroke Scale documentation, early ambulation, fall risk
41 n pretreatment National Institutes of Health Stroke Scale documented in 87.7% of patients was 11 (int
42 P<0.0001, the National Institutes of Health Stroke Scale-documented cohort; 73.0% versus 64.0%, abso
43 roke severity (National Institutes of Health Stroke Scale), functional status (functional independenc
44 severe stroke (National Institutes of Health Stroke Scale >/=10) occurred in 8 (4%) and was strongly
45 haemic stroke (National Institutes of Health Stroke Scale >3) versus those with acute intracerebral h
46 Stroke Prognostication using Age and the NIH Stroke Scale index, created by combining age in years pl
47 the following National Institutes of Health Stroke Scale items: motor arm, motor leg, or limb ataxia
48 e and baseline National Institutes of Health Stroke Scale, lack of recanalization, history of atrial
49 pidemia, lower National Institutes of Health Stroke Scale, lower blood pressure, and no large vessel
50 ct in baseline National Institutes of Health Stroke Scale <10) and occlusion site (greater benefit wi
51 d a less severe National Institute of Health Stroke Scale (median 6 versus 8), and a lower prevalence
53 as assessed by National Institutes of Health Stroke Scale (NIHSS [r = 0.225; p = 0.002]) and to advan
54 patients with National Institutes of Health Stroke Scale (NIHSS) < 6 and internal carotid artery (IC
55 h pretreatment National Institutes of Health Stroke Scale (NIHSS) < 6, onset-to-treatment time > 6 ho
56 years of age, National Institutes of Health Stroke Scale (NIHSS) </=25, and selected only on the app
58 ion (CTP) maps, National Institute of Health Stroke Scale (NIHSS) 10 and presenting beyond 6 hours fr
59 volumes measured on pMRI correlate with NIH stroke scale (NIHSS) and clinical outcome (mRS) at disch
60 baseline National Institutes of Health (NIH) Stroke Scale (NIHSS) and IV-tPA modified the risk of mor
61 ured using the National Institutes of Health Stroke Scale (NIHSS) and stroke infarct size was measure
62 scores of the National Institutes of Health Stroke Scale (NIHSS) and Stroke-Specific Quality of Life
63 s 5 and 30; the National Institute of Health Stroke Scale (NIHSS) at baseline, 24 h, and at days 5 (o
64 Median [IQR] National Institutes of Health Stroke Scale (NIHSS) at presentation was 12.5 (15.8), an
65 qual to 75% on National Institutes of Health Stroke Scale (NIHSS) between baseline and 24 hours, was
66 Claim-based National Institutes of Health Stroke Scale (NIHSS) categorized into minor (0-7), moder
67 were severe in most cases, with initial NIH stroke scale (NIHSS) higher in HM3 patients compared to
68 severity, the National Institutes of Health Stroke Scale (NIHSS) is an important predictor of patien
70 er decrease in National Institutes of Health Stroke Scale (NIHSS) over 24 hours and 90-day modified R
71 lation, higher National Institutes of Health Stroke Scale (NIHSS) score (>10), and isolated/combined
72 ), preoperative National Institute of Health Stroke Scale (NIHSS) score (score of 0-1 vs >=2), and pr
73 stratified by National Institutes of Health Stroke Scale (NIHSS) score (severe stroke > or =14, less
74 cording to the National Institutes of Health Stroke Scale (NIHSS) score and classified into 5 levels:
75 ays, change in National Institutes of Health Stroke Scale (NIHSS) score at 24 hours, all-cause mortal
76 o-needle time, National Institutes of Health Stroke Scale (NIHSS) score at day 2, expanded Treatment
78 18.1 minutes), National Institutes of Health Stroke Scale (NIHSS) score exceeding 12 vs a score of 0
79 oke onset; the National Institutes of Health Stroke Scale (NIHSS) score measured at the time of scann
80 indicated by a National Institutes of Health Stroke Scale (NIHSS) score of 0-5, who received intraven
82 mb weakness, a National Institutes of Health Stroke Scale (NIHSS) score of 3 or higher or aphasia, a
83 stroke, with a National Institutes of Health Stroke Scale (NIHSS) score of 5 or less (range, 0 to 42,
84 ith a baseline National Institutes of Health stroke scale (NIHSS) score of 6 or more who could be tre
85 c stroke and a National Institutes of Health Stroke Scale (NIHSS) score of 8-20 to treatment with int
86 0.022) and low National Institutes of Health Stroke Scale (NIHSS) score on admission (OR: NIHSS <4: 0
87 e assessed the National Institutes of Health Stroke Scale (NIHSS) score serially and functional outco
88 gly report the National Institutes of Health Stroke Scale (NIHSS) score using an International Classi
89 le, and median National Institutes of Health Stroke Scale (NIHSS) score was 17 (interquartile range [
90 the median US National Institutes of Health Stroke Scale (NIHSS) score was 19 (IQR 16-23) in the pla
91 edian baseline National Institutes of Health Stroke Scale (NIHSS) score was 5 (interquartile range 2-
93 uring PSR, the National Institutes of Health Stroke Scale (NIHSS) score worsened by a mean (SD) 2.5 (
94 8 (1.22-1.79); National Institutes of Health Stroke Scale (NIHSS) score, 1.20 (1.13-1.26) for each 5-
95 stment for age, National Institute of Health Stroke Scale (NIHSS) score, Alberta Stroke Program Early
96 se level (BGL), National Institute of Health Stroke Scale (NIHSS) score, and clinical parameters were
97 more points in National Institutes of Health Stroke Scale (NIHSS) score, but not as a result of cereb
98 high baseline National Institutes of Health Stroke Scale (NIHSS) score, larger ICH, presence of intr
99 age, baseline National Institutes of Health Stroke Scale (NIHSS) score, prestroke mRS score, history
101 tion; (2) lower National Institute of Health stroke scale (NIHSS) score; (3) no hypertension history.
103 improvement of National Institutes of Health Stroke Scale (NIHSS) scores at discharge from baseline.
104 of treatment, National Institutes of Health Stroke Scale (NIHSS) scores of 5 or higher, and lesions
105 strokes and US National Institutes of Health Stroke Scale (NIHSS) scores of 8-29 within 8 h of sympto
106 racy of serial National Institutes of Health Stroke Scale (NIHSS) scores to detect complete early rec
107 utes using the National Institutes of Health Stroke Scale (NIHSS) until movement to a catheterization
108 e range [IQR]) National Institutes of Health Stroke Scale (NIHSS) was 13 (8-19) in EVT versus 10 (6-1
110 (TCD) and the National Institutes of Health Stroke Scale (NIHSS) were used to monitor consecutive pa
111 ce between the National Institutes of Health Stroke Scale (NIHSS) within 6 h of stroke onset and NIHS
112 30 days, (ii) National Institutes of Health Stroke Scale (NIHSS) worsening at 2-5 days or Montreal C
113 clusion of the National Institutes of Health Stroke Scale (NIHSS), a measure of stroke severity not i
114 points on the National Institutes of Health Stroke Scale (NIHSS), attributed to parenchymal hematoma
115 including the National Institutes of Health stroke scale (NIHSS), the modified Rankin scale (mRS), t
119 cording to the National Institutes of Health Stroke Scale (NIHSS): the difference between the two gro
120 mented for the National Institutes of Health Stroke Scale (NIHSS, a 15-item neurological examination
121 ssessed on the National Institutes of Health Stroke Scale (NIHSS, a 42-point scale on which higher sc
122 defined by the National Institutes of Health Stroke Scale (NIHSS; minor, <=5; mild, 6-10; moderate, 1
123 easured by the National Institutes of Health Stroke Scale (NIHSS; range of 0-42, with a higher score
124 minor strokes (National Institutes of Health Stroke Scale [NIHSS] <= 5) with LVO, with or without add
125 ge = 78 years, National Institutes of Health Stroke Scale [NIHSS] = 10, onset to scan = 2.5 hours).
126 re included (mean age = 66 years, median NIH Stroke Scale [NIHSS] = 16, median time from symptom onse
127 le disability (National Institutes of Health Stroke Scale [NIHSS] score >/=6 and modified Rankin Scal
128 tion (baseline National Institutes of Health Stroke Scale [NIHSS] score >5), who had been functioning
130 minor stroke (National Institutes of Health Stroke Scale [NIHSS] score <=6) is not well established.
131 erebral cortex (National Institute of Health Stroke Scale [NIHSS] score 7-20) without previous disabi
132 mm Hg; median National Institutes of Health stroke scale [NIHSS] score 9 [IQR 5-16] points) were ran
133 stment for the National Institutes of Health Stroke Scale [NIHSS] score [8-19, indicating moderately
134 roke severity (National Institutes of Health Stroke Scale [NIHSS] score at admission), END, and favor
135 ery at day 90 (National Institutes of Health Stroke Scale [NIHSS] score of < or =1); secondary end po
136 minor stroke (National Institutes of Health Stroke Scale [NIHSS] score of 5 or less) and LVO (basila
137 ed with the US National Institutes of Health Stroke Scale [NIHSS] score), location (ie, dysphasia), p
138 tients: median National Institutes of Health Stroke Scale [NIHSS] score, 11 [interquartile range, 5-1
139 [57.6%]; median National Institute of Health Stroke Scale [NIHSS] score, 13.5 [IQR, 8.5-18.5]; intrav
140 sing clinical (National Institutes of Health Stroke Scale [NIHSS]) and imaging (infarct volume by dif
141 and clinical (National Institutes of Health Stroke Scale [NIHSS]) outcomes, safety measures (symptom
142 st 4 points on National Institutes of Health Stroke Scale [NIHSS]); and fatal intracerebral haemorrha
143 nical deficit (National Institutes of Health stroke scale, NIHSS score range: 8-23) and CT Perfusion
144 scores on the National Institutes of Health Stroke Scale of 11 (IQR 6-16) and median time from the o
147 e score on the National Institutes of Health Stroke Scale of less than 7 points (scores range from 0
150 least 8 on the National Institute of Health Stroke Scale or between 7 and 14 inclusive on the Glasgo
151 s in Pediatric National Institutes of Health Stroke Scale (PedNIHSS), Pediatric Stroke Outcome Measur
152 the Pediatric National Institutes of Health Stroke Scale (pedNIHSS), with pedNIHSS 0 indicating no s
153 n score on the National Institutes of Health Stroke Scale (range, 0 to 42, with higher scores indicat
155 onal measures (National Institutes of Health Stroke Scale, Rankin Disability Scale, Barthel Activitie
157 troke included National Institutes of Health stroke scale score >0, prior stroke, prior transient isc
158 severe stroke (National Institutes of Health Stroke Scale score >25), onset-to-treatment time >4.5 ho
159 line severity (National Institutes of Health Stroke Scale score >6), early BBB disruption was found t
160 95% CI 6%-31%; National Institutes of Health Stroke Scale score >8: 27% decrease in DTN time, 95% CI
161 haemic stroke (National Institutes of Health Stroke Scale score >=10) who received intravenous thromb
162 severe stroke (National Institutes of Health stroke scale score >=6) to randomisation, hypertension,
163 haemic stroke (National Institutes of Health Stroke Scale score <8) and assessed current and premorbi
164 r median (IQR) National Institutes of Health Stroke Scale score (15 [10-19] vs 17 [13-21], P < .001),
165 lower baseline National Institutes of Health Stroke Scale score (median, 12.5 [IQR, 7-17] vs 17 [IQR,
166 ute lesion volumes correlated with the acute stroke scale score (r = 0.56), the chronic stroke scale
167 e stroke scale score (r = 0.56), the chronic stroke scale score (r = 0.63), and chronic lesion volume
168 Chronic volumes correlated with the chronic stroke scale score (r = 0.86) and the Barthel index (r =
169 haemic stroke (National Institutes of Health Stroke Scale score 0-5) and intracranial occlusion or fo
171 roke severity (National Institutes of Health Stroke Scale score 6-8: 19% decrease in DTN time, 95% CI
172 severe (median National Institutes of Health Stroke Scale score 8 vs 5, p<0.002), were associated wit
173 women, median National Institutes of Health Stroke Scale score = 11, interquartile range = 6-17).
174 icantly higher National Institutes of Health Stroke Scale score and glucose on admission, and more of
175 higher baseline National Institute of Health Stroke Scale score and lower Alberta Stroke Program Earl
178 e (r = -0.42), National Institutes of Health Stroke Scale score at admission (r = -0.27), and modifie
181 and the median National Institutes of Health Stroke Scale score at presentation was 17 (interquartile
184 or increase in National Institutes of Health Stroke Scale score by >or=2 points and hemorrhage growth
185 vement (median National Institutes of Health Stroke Scale score change: tenecteplase, 6; alteplase, 1
186 vement (median National Institutes of Health Stroke Scale score change: tenecteplase, 7; alteplase, 2
187 dian change in National Institutes of Health Stroke Scale score from baseline to 24 h, was greater in
189 improvement in National Institutes of Health Stroke Scale score of >or=8 points at 30 days or a modif
190 =8 points or a National Institutes of Health Stroke Scale score of 0 hour or 1 24 hours after treatme
191 d TIA-S with a National Institutes of Health Stroke Scale score of 0 to 3 who presented to the emerge
192 s plus a National Institutes of Health (NIH) Stroke Scale score of 100 or higher (and hereafter refer
193 ars and median National Institutes of Health Stroke Scale score of 19 (interquartile range, 15-23).
194 (22.4%) had a National Institutes of Health Stroke Scale score of 5 or less and 5910 had complete da
197 stroke with a National Institutes of Health Stroke Scale score of 6 or higher before alteplase admin
198 mL), baseline National Institutes of Health Stroke Scale score of 6 or higher, and Glasgow Coma Scal
199 -82), baseline National Institutes of Health Stroke Scale score of 7 (4-11), and 260 (38%) were femal
200 17; p<0.0001), National Institutes of Health Stroke Scale score of greater than 5 at discharge (5.11,
202 on, the median National Institutes of Health Stroke Scale score was 10 (interquartile range, 4-18).
203 rs, the median National Institutes of Health Stroke Scale score was 11.0 (interquartile range, 6-17),
207 mean baseline National Institutes of Health Stroke Scale score was 13.6 (95% CI, 11.9-15.5), and the
209 The median National Institutes of Health Stroke Scale score was 17 (range, 3-35) and the median o
210 dian admission National Institutes of Health Stroke Scale score was 18 (interquartile range [IQR], 14
213 The median National Institutes of Health Stroke Scale score was 21 (interquartile range [IQR], 15
214 The median National Institutes of Health Stroke Scale score was 3 (interquartile range, 0-9) and
217 ic; the median National Institutes of Health Stroke Scale score was 6.5 [IQR, 4-14]; and the median l
220 ermined by the National Institutes of Health Stroke Scale score was not related to preventability of
222 sion, age, and National Institutes of Health Stroke Scale score were significant after multivariate a
223 roke severity (National Institutes of Health Stroke Scale score), site of occlusion (internal carotid
225 trokes (median National Institutes of Health Stroke Scale score, 10 [IQR, 5 to 17] vs 7 [IQR, 4 to 14
226 olysis (median National Institutes of Health Stroke Scale score, 14; interquartile range, 9-17), 55%
227 edian baseline National Institutes of Health Stroke Scale score, 15 vs 17 [P = .03]; median diffusion
228 uartile range] National Institutes of Health Stroke Scale score, 17 [14-21]) were included in the ana
229 years; median National Institutes of Health Stroke Scale score, 17 [IQR, 11-21]); 949 (69%) comprise
230 years; median National Institutes of Health Stroke Scale score, 5; mean baseline oxygen saturation,
231 evere baseline National Institutes of Health Stroke Scale score, absence of specific abnormalities (e
233 Age, sex, National Institutes of Health Stroke Scale score, and intubation did not affect delays
234 line DWI, ADC, National Institutes of Health Stroke Scale score, and stroke symptom sidedness as inpu
235 usted for age, National Institutes of Health Stroke scale score, and the Alberta Stroke Program Early
236 sex, baseline National Institutes of Health Stroke Scale score, ASPECTS, occlusion location, site, a
237 r the baseline National Institutes of Health Stroke Scale score, diffusion-weighted imaging Alberta S
238 luding age and National Institutes of Health Stroke Scale score, generated by an independent statisti
239 e race, higher National Institutes of Health Stroke Scale score, higher serum glucose, atrial fibrill
240 for admission National Institutes of Health Stroke Scale score, history of atrial fibrillation, prem
241 /=15) baseline National Institutes of Health Stroke Scale score, larger (>/=15 mL) ICH volume, greate
242 ncluded higher National Institutes of Health Stroke Scale score, longer onset-to-arrival time, and hi
243 g for age, sex, National Institute of Health Stroke Scale score, onset-to-needle time, and occlusion
244 usted for age, National Institutes of Health Stroke Scale score, previous stroke, atrial fibrillation
245 age, baseline National Institutes of Health Stroke Scale score, sex, and baseline blood glucose conc
246 criteria (age, National Institutes of Health Stroke Scale score, time from onset, baseline modified R
250 as those with National Institutes of Health Stroke Scale scores < 4 within seven days of symptom ons
252 graphic scans, National Institutes of Health Stroke Scale scores at those times, and proximal middle
253 d as change in National Institutes of Health Stroke Scale scores between the acute and 1-month assess
255 esent with low National Institutes of Health Stroke Scale scores or medium or distal vessel occlusion
257 hypertension, National Institutes of Health Stroke Scale scores, collateral status, and the use of m
258 logical scores (National Institute of Health Stroke Scale scores, NIHSS, and Alberta Stroke Program E
259 initial National Institutes of Health (NIH) stroke scale scores, outcome NIH stroke scale scores, an
261 ne and 24-hour National Institutes of Health Stroke Scale scores; and history of hypertension, diabet
262 greater neurological improvement on the NIH Stroke Scale than high-dose aptiganel patients (mean imp
269 The Modified National Institutes of Health Stroke Scale was used to identify neurologic abnormaliti
270 ore <10 on the National Institutes of Health Stroke Scale) within 2 h of initiation of intravenous th
271 sex, baseline National Institutes of Health Stroke Scale, world region, tissue plasminogen activator
272 e of a 4-point National Institutes of Health Stroke Scale worsening and the proportion of serious adv